Successful go-public transaction and over $475 million raised this year provides cash runway through multiple clinical ...

EST Oruka Therapeutics (ORKA) files to sell 8.72M shares of common stock for holders Published first on TheFly – the ultimate ...

Wedbush analyst David Nierengarten maintained a Buy rating on Oruka Therapeutics (ORKA – Research Report) today and set a price target of ...

Oruka Therapeutics (NASDAQ:ORKA – Get Free Report) is one of 39 publicly-traded companies in the “Diagnostic substances” industry, but how does it contrast to its competitors? We will compare Oruka ...

Oruka Therapeutics (NASDAQ:ORKA – Get Free Report) is one of 39 public companies in the “Diagnostic substances” industry, but how does it weigh in compared to its peers? We will compare Oruka ...

There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.

On Thursday, Stifel, a financial services company, announced the initiation of coverage on Oruka Therapeutics (NASDAQ: ORKA) with a Buy rating and a price target set at $49.00. The firm's positive ...

With our newsletters and social media channels.